Successful treatment of a patient with NSCLC carrying uncommon compound EGFR G719X and S768I mutations using osimertinib: A case report

The discovery of epidermal growth factor receptor (EGFR) somatic mutations and the availability of tyrosine kinase inhibitors (TKIs) as targeted therapies have altered the therapeutic prospects of advanced non-small-cell lung cancer (NSCLC). G719X and S768I are uncommon mutations, and they often exi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Int Med Res
Main Authors: Cai, Yangyang, Wang, Yizhuo, Sun, Jingnan, Wang, Xu, Xu, Yinghui, Sun, Chao, Guo, Ye, Sun, Mengyao, Ma, Kewei
Format: Artigo
Sprog:Inglês
Udgivet: SAGE Publications 2020
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7273558/
https://ncbi.nlm.nih.gov/pubmed/32493093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060520928793
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker